Use of Adiana Tubal Occlusive Devices in Women With Hydrosalpinx Prior to In Vitro Fertilization

Inclusion Criteria: * Are willing to participate in this clinical study * Are able to comprehend and give informed consent for participation in this study * Have read, understood and signed an informed consent form * Have been unable to achieve pregnancy after trying for 1 year or greater and who have unilateral or bilateral hydrosalpinges as evidenced by laparoscopy or ultrasound or HSG * Have a Day #3 serum FSH\<10, and Day #3 Estradiol\<80 * Recipient women undergoing a ovum donor cycle the donor must have a Day 3 serum FSH \< 10 and Day 3 Estradiol \< 80 * Have an antral follicle count 10 or greater for both ovaries combined, if women using ovum donor (follicle count) will be based on eligible donor * Have a desire to receive treatment for their HS * Are willing to undergo a hysterosalpingogram (HSG) 3 months after ADIANA placement to confirm proximal tubal occlusion Exclusion Criteria: * Active or recent upper or lower pelvic infection * Known hypersensitivity to nickel as confirmed by skin test * Known allergy to contrast media * Pregnancy or suspected pregnancy * Delivery or termination of pregnancy less than six weeks prior to Adiana placements * BMI \> 35 * Abnormal pap smear (CIN2 or greater abnormality) within the past year * Pelvic malignancy * Severely retroverted uterus * Evidence of intrauterine abnormalities such as submucous fibroids, polyps, intrauterine adhesions or presence of a uterine septum * Abnormal Clomid Challenge Test or abnormal lab values on D…